Cysteine prodrugs to treat schizophrenia and drug addiction
US7829709B1 · kind B1 · utility
6Cited by
1References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 11, 2008 |
| Grant date | Nov 9, 2010 |
| Priority date | — |
| Expiry date | Aug 11, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/30
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides cysteine prodrugs for the treatment of schizophrenia and drug addiction. The invention further encompasses pharmaceutical compositions containing prodrugs and methods of using the prodrugs and compositions for treatment of schizophrenia and drug addiction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.